Publicaciones en colaboración con investigadores/as de Universidad del País Vasco/Euskal Herriko Unibertsitatea (48)

2024

  1. Cancer is not a risk factor for severe COVID-19 in children, except in patients with recent allogeneic hematopoietic stem cell transplantation or comorbidities

    Pediatric Blood and Cancer, Vol. 71, Núm. 8

  2. CircRNAome of Childhood Acute Lymphoblastic Leukemia: Deciphering Subtype-Specific Expression Profiles and Involvement in TCF3::PBX1 ALL

    International Journal of Molecular Sciences, Vol. 25, Núm. 3

  3. The ECHO recommendations for dealing with vinblastine shortage affecting standard treatment of systemic Langerhans cell histiocytosis

    Pediatric Blood and Cancer

2023

  1. Analysis of germline variants in pediatric patients diagnosed with desmoid tumors and nuchal-type fibromas

    Translational Pediatrics, Vol. 12, Núm. 9, pp. 1715-1724

  2. Decoding the molecular heterogeneity of pediatric monomorphic post–solid organ transplant lymphoproliferative disorders

    Blood, Vol. 142, Núm. 5, pp. 434-445

  3. How do hospitalised children die? The context of death and end-of-life decision-making

    Journal of Paediatrics and Child Health, Vol. 59, Núm. 4, pp. 625-630

  4. Identification of germline cancer predisposition variants in pediatric sarcoma patients from somatic tumor testing

    Scientific Reports, Vol. 13, Núm. 1

2022

  1. A Three-Protein Panel to Support the Diagnosis of Sepsis in Children

    Journal of Clinical Medicine, Vol. 11, Núm. 6

  2. Atención pediátrica en el Hospital Universitario Cruces. Avances hacia la asistencia especializada, integral y humanizada en el Servicio de Pediatría

    Gaceta médica de Bilbao: Revista oficial de la Academia de Ciencias Médicas de Bilbao. Información para profesionales sanitarios, Vol. 119, Núm. 1, pp. 53-56

  3. Clinical management of the acute complications of sickle cell anemia: 11 years of experience in a tertiary hospital

    Anales de Pediatria, Vol. 97, Núm. 1, pp. 4-11

  4. Current status of precision medicine in pediatric oncology in Spain: a consensus report by the Spanish Society of Paediatric Haematology and Oncology (SEHOP)

    Clinical and Translational Oncology, Vol. 24, Núm. 5, pp. 809-815

  5. Diverse mutations and structural variations contribute to Notch signaling deregulation in paediatric T-cell lymphoblastic lymphoma

    Pediatric Blood and Cancer, Vol. 69, Núm. 11

  6. El cribado de hemoglobinopatías

    Boletín de la Sociedad Vasco-Navarra de pediatría = Euskal Herriko Pediatria Elkartearen aldizkaria, Núm. 123, pp. 97-99

  7. Identification and Functional Analysis of a Novel CTNNB1 Mutation in Pediatric Medulloblastoma

    Cancers, Vol. 14, Núm. 2

  8. Langerhans cell histiocytosis. Advances in pathogenesis and clinical practice

    Anales de Pediatria, Vol. 97, Núm. 2, pp. 130.e1-130.e7

  9. Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma

    New England Journal of Medicine, Vol. 386, Núm. 26, pp. 2471-2481

  10. Seguimiento de pacientes con enfermedades metabólicas hereditarias

    Boletín de la Sociedad Vasco-Navarra de pediatría = Euskal Herriko Pediatria Elkartearen aldizkaria, Núm. 123, pp. 100-102

  11. Splicing-Disrupting Mutations in Inherited Predisposition to Solid Pediatric Cancer

    Cancers, Vol. 14, Núm. 23

2021

  1. Clinical value of NGS genomic studies for clinical management of pediatric and young adult bone sarcomas

    Cancers, Vol. 13, Núm. 21

  2. Importance of timely treatment initiation in infantile-onset pompe disease, a single-centre experience

    Children, Vol. 8, Núm. 11